anti-BCL2-Like 12 (Proline Rich) (BCL2L12) Anticorps

The protein encoded by BCL2L12 belongs to the BCL-2 protein family. De plus, nous expédions BCL2L12 Protéines (5) et et beaucoup plus de produits pour cette protéine.

afficher tous les anticorps Gène GeneID UniProt
BCL2L12 83596 Q9HB09
BCL2L12 75736  
BCL2L12 361567  
Comment commander chez anticorps-enligne
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Commandez enligne
  • orders@anticorps-enligne.fr

Top anti-BCL2L12 Anticorps sur anticorps-enligne.fr

Showing 10 out of 68 products:

Catalogue No. Reactivité Hôte Conjugué Application Images Quantité Livraison Prix Détails
Boeuf (Vache) Lapin Inconjugué WB 100 μL 2 to 3 Days
$289.00
Détails
Boeuf (Vache) Lapin Inconjugué WB 100 μL 11 to 14 Days
$551.83
Détails
Humain Lapin Inconjugué ELISA, ICC, IF, WB Western blot analysis of extracts from CoLo cells, using BCL2L12 antibody. ABIN6274901 staining HepG2 by IF/ICC. The sample were fixed with PFA and permeabilized in 0.1% Triton X-100,then blocked in 10% serum for 45 minutes at 25°C. The primary antibody was diluted at 1/200 and incubated with the sample for 1 hour at 37°C. An Alexa Fluor 594 conjugated goat anti-rabbit IgG (H+L) Ab, diluted at 1/600, was used as the secondary antibody. 100 μL 11 to 12 Days
$390.77
Détails
Humain Lapin Inconjugué WB Western blot analysis in T47D cell line lysates (35ug/lane). 400 μL 2 to 3 Days
$515.63
Détails
Humain Lapin Inconjugué IF (p), IHC (p), WB Formalin-fixed and paraffin embedded mouse embryo labeled with Rabbit Anti-BCL2L12 Polyclonal Antibody, Unconjugated (ABIN714896) at 1:200 followed by conjugation to the secondary antibody and DAB staining 100 μL 3 to 7 Days
$317.90
Détails
Humain Lapin Inconjugué ELISA, WB   100 μL Disponible
$363.46
Détails
Humain Lapin Inconjugué IHC, IHC (p), WB   100 μL 11 to 14 Days
$537.17
Détails
Humain Lapin Inconjugué IHC (p), WB IHC-P Image BCL2L12 antibody detects BCL2L12 protein at cytosol and nucleus on human colon carcinoma by immunohistochemical analysis. Sample: Paraffin-embedded colon carcinoma tissue. BCL2L12 antibody , dilution: 1:500. IHC-P Image BCL2L12 antibody detects BCL2L12 protein at cytosol on U87 xenograft by immunohistochemical analysis. Sample: Paraffin-embedded U87 xenograft. BCL2L12 antibody , dilution: 1:500. 100 μL 3 to 4 Days
$466.18
Détails
Humain Lapin Alexa Fluor 594 IF (p)   100 μL 14 to 21 Days
$416.90
Détails
Humain Souris Inconjugué WB Western Blot analysis of BCL2L12 expression in transfected 293T cell line by BCL2L12 MaxPab polyclonal antibody.Lane 1: BCL2L12 transfected lysate(36.63 KDa).Lane 2: Non-transfected lysate. 50 μg 11 to 12 Days
$440.00
Détails

Plus d’anticorps contre BCL2L12 partenaires d’interaction

Human BCL2-Like 12 (Proline Rich) (BCL2L12) interaction partners

  1. Increased BCL2L12 v.4 mRNA expression was associated with markers of unfavorable prognosis namely, advanced tumor, ER- (p=0.015)/PR-, Ki-67-positivity and high NPI (Nottingham prognostic index) score

  2. Bcl2L12 is positively correlated with Th2 cytokine levels in the nasal mucosa of chronic rhinosinusitis with accompanying nasal allergy (CRSa) patients. Bcl2L12 contributes to the Th2 polarization, which may be a novel therapeutic target in the treatment of CRSa.

  3. Bcl2L12 plays a crucial role in the induction of Th2 polarization and allergic response in the intestine. The Bcl2L12 in CD4(+) T cells may be a potential target for the treatment of food allergy.

  4. Bcl2L12 is a critical factor in the induction of aberrant Th2 polarization by upregulating Th2 responses and downregulating Th2 cell apoptosis

  5. Peripheral CD4+ T cells express high levels of Bcl2L12 in patients with ulcerative colitis. Bcl2L12 mediates PAR2-induced Th2 cell development to promote inflammation in the pathogenesis of ulcerative colitis.

  6. Activation of PAR2 inhibits the expression of IL-10 in B cells, which can be reversed by treating B cells with Bcl2L12 shRNA-carrying liposomes.

  7. BCL2L12 is a new prognostic biomarker for favorable outcome in diffuse large B-cell lymphoma patients on rituximab.

  8. stress hormone cortisol suppresses p53 in hepatocellular carcinoma via enhancing Bcl2L12 expression

  9. TNF-alpha suppresses IL-10 in peripheral B cells via up-regulating Bcl2L12 in patients with ulcerative colitis.

  10. miR-125a-5p inhibits cell proliferation and induces apoptosis in colon cancer cells via targeting BCL2, BCL2L12 and Mcl-1.

  11. Identify 50 novel BCL2L12 splice variants in human tumor cell lines.

  12. Results show that high Bcl2L12 mRNA expression was associated with the high-grade breast cancer and triple-negative (TNBC) subtype. Also, the interplay between Bcl2L12 and its variant may be associated with high lymph node metastasis in non-TNBC tumors.

  13. CD82 regulated BCL2L12 expression via STAT5A and AKT signaling and stimulated proliferation and engrafting of leukemia cells.

  14. Bcl2L12 retains a BH3-like domain, which is important for its anti-apoptotic property.

  15. Data indicate that BCL2-like 12 (proline rich) protein BCL2L12 mRNA levels can distinguish women with breast cancer from healthy controls.

  16. Data indicate that BCL2L12 expression levels were associated with poor disease-free survival of the high-grade TaT1 bladder cancer patients.

  17. Bcl2L12 was previously shown to inhibit apoptosis through binding to caspase 7.

  18. cisplatin treatment induced a time-dependent apoptosis in glioblastoma cells, at least partially via downregulation of BCL2L12 gene expression.

  19. Acute myeloid leukemia patients have a lower level of BCL2L12 gene expression.

  20. Protein made from F17F mutant BCL2L12 transcript bound p53, inhibited UV-induced apoptosis more efficiently than WT BCL2L12, and reduced endogenous p53 target gene transcription.

Mouse (Murine) BCL2-Like 12 (Proline Rich) (BCL2L12) interaction partners

  1. Bcl2L12 plays a crucial role in the induction of Th2 polarization and allergic response in the intestine. The Bcl2L12 in CD4(+) T cells may be a potential target for the treatment of food allergy.

  2. nuclear Bcl2L12 physically and functionally interacts with the p53 tumor suppressor

  3. Data show that apoptotic defect in Irf3(-/-)Bcl2l12(-/-) MEFs was rescued by the ectopic expression of Bcl2L12, but not IRF3.

BCL2L12 profil antigène

Profil protéine

The protein encoded by this gene belongs to the BCL-2 protein family. BCL-2 family members form hetero- or homodimers and act as anti- or pro-apoptotic regulators that are involved in a wide variety of cellular activities. This protein contains a Bcl-2 homology domain 2 (BH2). The function of this gene has not yet been determined. Two alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported.

Gene names and symbols associated with BCL2L12

  • BCL2 like 12 (BCL2L12) anticorps
  • BCL2-like 12 (proline rich) (Bcl2l12) anticorps
  • BCL2 like 12 (Bcl2l12) anticorps
  • 2810475P17Rik anticorps
  • 5430429M05Rik anticorps
  • Bcl-L12 anticorps
  • Bcl2-L12 anticorps

Protein level used designations for BCL2L12

Bcl-2 related proline-rich protein , bcl-2-like protein 12 , bcl-2-related proline-rich protein , bcl2-L-12

GENE ID SPECIES
83596 Homo sapiens
100688537 Canis lupus familiaris
533338 Bos taurus
75736 Mus musculus
361567 Rattus norvegicus
Fournisseurs de qualité sélectionnés pour anti-BCL2L12 (BCL2L12) Anticorps
Avez-vous cherché autre chose?